SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Biotech
Biotech
Page 4 of 18
Finance
Biden’s new executive order triggers new front in U.S.-China economic competition
By
Tristan Bove
September 12, 2022
Biden to spur biomanufacturing, reduce reliance on China with executive order
By
Riley Griffin
and
Bloomberg
September 10, 2022
Health
Parents are becoming drug developers to find a cure for their children’s rare diseases
By
Jared Whitlock
and
Kaiser Health News
July 21, 2022
Commentary
ESG investors shouldn’t ignore biotech’s potential to deliver change
By
Michelle McMurry-Heath
May 2, 2022
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Finance
Investors are moving away from biotech stocks as COVID wanes
By
Angelica Peebles
and
Bloomberg
February 14, 2022
Health
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By
Jeremy Kahn
January 7, 2022
Health
Omicron vaccine to begin clinical trial in South Africa
By
Jeremy Kahn
December 6, 2021
Magazine
Moderna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?
By
Rey Mashayekhi
December 2, 2021
Tech
DeepMind spins out new Alphabet company focused on drug discovery
By
Jeremy Kahn
November 4, 2021
Tech
Thera-who? These biotech firms are looking to push what’s possible with blood
By
Rey Mashayekhi
October 22, 2021
Tech
DeepMind unveils how it solved a 50-year-old scientific challenge that could speed drug discovery
By
Jeremy Kahn
July 15, 2021
Finance
What is it really like to take your company public via a SPAC? One Boston biotech shares its journey
By
Adam Bluestein
July 8, 2021
Health
Regeneron’s new genetic discovery for obesity could be a breakthrough for weight loss drugs
By
Erika Fry
July 1, 2021
Health
Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
By
Cristin Flanagan
and
Bloomberg
June 9, 2021
Most Popular
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh
Tech
‘Yes, you read that correctly’: Tesla pay committee pitches $1 trillion pact to keep Elon Musk as CEO for long term
By
Nick Lichtenberg
Success
Millionaire Alexis Ohanian walked out of the LSAT 20 minutes in, went to a Waffle House, and decided he was ‘gonna...
By
Preston Fore